12411 related articles for article (PubMed ID: 12094637)
1. [Gene modified tumor vaccines in therapy of malignant melanoma].
Wysocki PJ; Karczewska A; Mackiewicz A
Otolaryngol Pol; 2002; 56(2):147-53. PubMed ID: 12094637
[TBL] [Abstract][Full Text] [Related]
2. Genetically modified tumour vaccines (GMTV) in melanoma clinical trials.
Nawrocki S; Murawa P; Malicki J; Kapcinska M; Gryska K; Izycki D; Kaczmarek A; Laciak M; Czapczyk A; Karczewska A; Rose-John S; Mackiewicz A
Immunol Lett; 2000 Sep; 74(1):81-6. PubMed ID: 10996632
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of malignant melanoma.
Kadison AS; Morton DL
Surg Clin North Am; 2003 Apr; 83(2):343-70. PubMed ID: 12744613
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic vaccines against melanoma and colorectal cancer.
Tartaglia J; Bonnet MC; Berinstein N; Barber B; Klein M; Moingeon P
Vaccine; 2001 Mar; 19(17-19):2571-5. PubMed ID: 11257394
[TBL] [Abstract][Full Text] [Related]
5. Cancer vaccines with emphasis on a viral oncolysate melanoma vaccine.
Horvath JC; Horak A; Sinkovics JG; Pritchard M; Pendleton S; Horvath E
Acta Microbiol Immunol Hung; 1999; 46(1):1-20. PubMed ID: 10331063
[TBL] [Abstract][Full Text] [Related]
6. Double-copy bicistronic retroviral vector platform for gene therapy and tissue engineering: application to melanoma vaccine development.
Wiznerowicz M; Fong AZ; Mackiewicz A; Hawley RG
Gene Ther; 1997 Oct; 4(10):1061-8. PubMed ID: 9415312
[TBL] [Abstract][Full Text] [Related]
7. Melanoma vaccines.
Yang JC
Cancer J; 2011; 17(5):277-82. PubMed ID: 21952276
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cell vaccines in melanoma: from promise to proof?
Lesterhuis WJ; Aarntzen EH; De Vries IJ; Schuurhuis DH; Figdor CG; Adema GJ; Punt CJ
Crit Rev Oncol Hematol; 2008 May; 66(2):118-34. PubMed ID: 18262431
[TBL] [Abstract][Full Text] [Related]
9. Immune responses in the draining lymph nodes against cancer: implications for immunotherapy.
Shu S; Cochran AJ; Huang RR; Morton DL; Maecker HT
Cancer Metastasis Rev; 2006 Jun; 25(2):233-42. PubMed ID: 16770535
[TBL] [Abstract][Full Text] [Related]
10. Advances in the non-surgical treatment of melanoma.
Hersey P
Expert Opin Investig Drugs; 2002 Jan; 11(1):75-85. PubMed ID: 11772323
[TBL] [Abstract][Full Text] [Related]
11. Immunological therapy of human tumors by gene-modified cellular vaccines.
Parmiani G
Folia Biol (Praha); 2000; 46(6):207-9. PubMed ID: 11140852
[No Abstract] [Full Text] [Related]
12. Strategies to enhance the therapeutic activity of cancer vaccines: using melanoma as a model.
Berinstein NL
Ann N Y Acad Sci; 2009 Sep; 1174():107-17. PubMed ID: 19769743
[TBL] [Abstract][Full Text] [Related]
13. Vaccine therapy for patients with melanoma.
Haigh PI; Difronzo LA; Gammon G; Morton DL
Oncology (Williston Park); 1999 Nov; 13(11):1561-74; discussion 1574 passim. PubMed ID: 10581603
[TBL] [Abstract][Full Text] [Related]
14. Melacine: an allogeneic melanoma tumor cell lysate vaccine.
Sosman JA; Sondak VK
Expert Rev Vaccines; 2003 Jun; 2(3):353-68. PubMed ID: 12903801
[TBL] [Abstract][Full Text] [Related]
15. Tumor antigens and tumor vaccines: peptides as immunogens.
Slingluff CL
Semin Surg Oncol; 1996; 12(6):446-53. PubMed ID: 8914209
[TBL] [Abstract][Full Text] [Related]
16. [New aspects of immunotherapy of malignant melanoma].
Enk A
Praxis (Bern 1994); 2001 Mar; 90(10):403-6. PubMed ID: 11305186
[TBL] [Abstract][Full Text] [Related]
17. [Vaccine strategies against melanoma].
Ghiringhelli F; Zitvogel L
Med Sci (Paris); 2006 Feb; 22(2):183-7. PubMed ID: 16457760
[TBL] [Abstract][Full Text] [Related]
18. Recent advances and hurdles in melanoma immunotherapy.
Jandus C; Speiser D; Romero P
Pigment Cell Melanoma Res; 2009 Dec; 22(6):711-23. PubMed ID: 19735459
[TBL] [Abstract][Full Text] [Related]
19. Melanoma vaccines: early progress and future promises.
Zarour HM; Kirkwood JM
Semin Cutan Med Surg; 2003 Mar; 22(1):68-75. PubMed ID: 12773015
[TBL] [Abstract][Full Text] [Related]
20. Results of clinical trials with an allogenic melanoma tumor cell lysate vaccine: Melacine.
Sondak VK; Sosman JA
Semin Cancer Biol; 2003 Dec; 13(6):409-15. PubMed ID: 15001159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]